Broviac catheter-related bacteremia in oncology patients
E. D. Shapiro, E. R. Wald, K. A. Nelson and K. N. Spiegelman
In 27 pediatric oncology patients (median age, 2 years) undergoing
chemotherapy for malignant tumours, Silastic Broviac catheters were placed
to provide vascular access. The catheters were in place for a total of 174
patient-months. There were 14 episodes of Broviac catheter-related
bacteremia or fungemia that occurred in six patients: one patient had six
bacteremic episodes, one patient had four episodes, and four patients each
had one bacteremic episode. Cultures of blood drawn from Broviac catheter
were positive in all instances, and in 12 of 14 samples drawn from the
peripheral vein. The most common initial symptoms were fever and chills.
The species causing the infections were Enterobacter cloacae (three cases),
Staphylococcus epidermidis (three cases), Staphylococcus aureus (three
cases), Klebsiella pneumoniae (two cases), Escherichia coli (two cases),
Pseudomonas dentrificans, Pseudomonas aeruginosa, and Candida tropicalis.
Antimicrobials administered through the catheter cured the infection in ten
of the 11 cases in which they were used.
